Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis

BACKGROUND: The treatment of tuberous sclerosis complex (TSC) using mammalian target of rapamycin (mTOR) inhibitors is clinically promising. The aim of the present study was to evaluate the efficacy and safety of mTOR inhibitors for improving the clinical symptoms of TSC. METHODS: We performed a sys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Orphanet J Rare Dis
Autores principales: Li, Min, Zhou, Ying, Chen, Chaoyang, Yang, Ting, Zhou, Shuang, Chen, Shuqing, Wu, Ye, Cui, Yimin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373010/
https://ncbi.nlm.nih.gov/pubmed/30760308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-019-1012-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares